Figure 2. Time to First Incidence of Any Component of the Primary Composite End Point and Time to Core MACE.
A, The primary composite end point consisted of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, and hospitalization for unstable angina. Median (Q1-Q3) observation time was 41.3 (36.0-47.5) months for patients receiving omega-3 CA and 41.4 (35.9-47.4) months for patients receiving corn oil. B, Core major adverse cardiovascular events (MACE) included cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. Median (Q1-Q3) observation time of 41.5 (36.6-47.8) months for patients receiving omega-3 CA and 41.6 (36.8-47.4) months for patients receiving corn oil.